Literature DB >> 8848348

Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor down-regulation.

L Thai1, J M Galluzzo, E C McCook, F J Seidler, T A Slotkin.   

Abstract

Ordinarily, beta-adrenergic receptors and responses linked to the receptors increase with development but in the liver, beta-receptors are higher in the fetus and neonate than in adulthood. We examined how hepatic beta-receptor signaling mediated through adenylyl cyclase is regulated in rats of different ages. In each case, animals were pretreated with isoproterenol for 4 d, and on the 5th d, hepatic membrane preparations were examined for adenylyl cyclase activity and receptor binding capabilities. Uniquely in 6-d-old animals, the cyclase response to isoproterenol was enhanced by chronic pretreatment, caused by heterologous sensitization mediated through effects on total catalytic activity (increased response to forskolin-Mn2+) and on G-protein coupling (enhanced effect of fluoride and increased GTP dependence of basal activity). Isoproterenol pretreatment failed to cause beta-receptor down-regulation in 6-d-old animals, but by 15 d of age, down-regulation was detected along with slight desensitization of the cyclase response. However, at 25 d, neither effect was present. In adulthood, repeated isoproterenol administration failed to cause cyclase desensitization but did reduce beta-receptor numbers; the loss of receptors was still unusual in that beta-receptor down-regulation could be achieved with either isoproterenol or with methoxamine, an alpha-receptor agonist. The results indicate that, early in development, hepatic beta-receptor-mediated responses are enhanced, not desensitized, after chronic stimulation. These effects would foster responsiveness of hepatic gluconeogenesis in the face of the massive adrenergic stimulation associated with the transition from fetal to neonatal life. In adulthood, when receptor numbers are far lower than in the neonate, the inability to desensitize the signaling cascade despite receptor down-regulation would serve to maintain the response to catecholamines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8848348     DOI: 10.1203/00006450-199604000-00023

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Moderate global reduction in maternal nutrition has differential stage of gestation specific effects on {beta}1- and {beta}2-adrenergic receptors in the fetal baboon liver.

Authors:  Amrita Kamat; Mark J Nijland; Thomas J McDonald; Laura A Cox; Peter W Nathanielsz; Cun Li
Journal:  Reprod Sci       Date:  2010-11-15       Impact factor: 3.060

2.  Terbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2012-07-16       Impact factor: 3.763

3.  Oxidative stress from diverse developmental neurotoxicants: antioxidants protect against lipid peroxidation without preventing cell loss.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2009-12-11       Impact factor: 3.763

4.  Developmental DSP4 effects on cortical Arc expression.

Authors:  Jeff Sanders
Journal:  Neurosci Lett       Date:  2016-03-03       Impact factor: 3.046

5.  Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood.

Authors:  Dan Qiao; Frederic J Seidler; Charlotte A Tate; Mandy M Cousins; Theodore A Slotkin
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

6.  Screening for developmental neurotoxicity using PC12 cells: comparisons of organophosphates with a carbamate, an organochlorine, and divalent nickel.

Authors:  Theodore A Slotkin; Emiko A MacKillop; Ian T Ryde; Charlotte A Tate; Frederic J Seidler
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

7.  Developmental neurotoxicity of perfluorinated chemicals modeled in vitro.

Authors:  Theodore A Slotkin; Emiko A MacKillop; Ronald L Melnick; Kristina A Thayer; Frederic J Seidler
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.